Showing results (81-90 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|February 14, 2025
Hepatic adverse events associated with anaplastic lymphoma kinase tyrosine kinase inhibitors: a disproportionality analysis based on FAERS database and analysis of drug-gene interaction networkYan Huo, Minghua Ma, Weiwei Tian, et al.Expert Opinion on Drug Safety|February 19, 2025
What does real-world data reveal about cangrelor's safety? An analysis of FDA adverse event reporting system (FAERS) databaseZhaojun Wang, Junhang Zhang, Donglei Shi, et al.Expert Opinion on Drug Safety|November 4, 2024
Adverse events associated with aromatase inhibitors: an analysis of real-world datasets and drug-gene interaction networkSi-Qi Zhang, Shujing Jia, Xiang Li, et al.Expert Opinion on Drug Safety|November 1, 2025
Safety and efficacy of atosiban for fetomaternal resuscitation following severe placental abruption in preparation for an emergency cesarean section: a narrative reviewHein J Odendaal, Ronald F LamontExpert Opinion on Drug Safety|September 25, 2025
Prolonged use of benzodiazepine in primary health care: evaluation of effectiveness, dependence and cognitive functionJúlia Casanova Durante, Amanda Gomes Dantas, Fabiana Coelho Inouye, et al.Expert Opinion on Drug Safety|December 18, 2020
Drug induced stuttering: pharmacovigilance dataThierry Trenque, Aurore Morel, Agathe Trenque, et al.Expert Opinion on Drug Safety|April 2, 2020
Cardiovascular safety and effectiveness of vildagliptin in patients with type 2 diabetes mellitus: a 3-year, large-scale post-marketing surveillance in JapanYosuke Ishida, Hiroki Murayama, Yohei Shinfuku, et al.Expert Opinion on Drug Safety|April 7, 2020
Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluationA Zangrilli, M Bavetta, L BianchiExpert Opinion on Drug Safety|December 24, 2019
Safety of nalmefene for the treatment of alcohol use disorder: an updateHugo López-Pelayo, Paola Zuluaga, Elsa Caballeria, et al.Expert Opinion on Drug Safety|January 25, 2020
An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's diseaseAndrea Haake, Kevin Nguyen, Lauren Friedman, et al.Pageof 281